Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Menu dropdown menu Search search

Search Results for product approval

Sort by:

Recent Relevant

05.05.2026

Viridian Therapeutics Reports Positive Phase 3 Results for Thyroid Eye Disease Drug

Eyewire News
Lenz Therapeutics Submits UK Marketing Application for Presbyopia Eye Drop Vizz image

04.21.2026

Lenz Therapeutics Submits UK Marketing Application for Presbyopia Eye Drop Vizz

Eyewire News
MeiraGTx Announces the Acquisition of XLRP Therapy from J&J image

04.17.2026

MeiraGTx Announces the Acquisition of XLRP Therapy From J&J

Eyewire News

04.16.2026

Glaukos Highlights Sustainability Progress in 2025 Report

Eyewire News
Genentech Secures FDA Approval for Extended Use of Vabysmo in Retinal Vein Occlusion image

04.10.2026

Genentech Secures FDA Approval for Extended Use of Vabysmo in Retinal Vein Occlusion

Eyewire News
Cassini and Leica Microsystems Collaborate to Enhance Intraoperative Guidance for Cataract Surgery image

04.09.2026

Cassini and Leica Microsystems Collaborate to Enhance Intraoperative Guidance for Cataract Surgery

Eyewire News
Tenpoint Therapeutics Launches Yuvezzi, a First-of-Its-Kind Eye Drop for Presbyopia in the US image

03.30.2026

Tenpoint Therapeutics Launches Yuvezzi Presbyopia Eye Drop in the US

Eyewire News
Apotex Expands Canadian Ophthalmology Portfolio With Health Canada's Approval of Clobivis image

03.26.2026

Apotex Expands Canadian Ophthalmology Portfolio With Health Canada's Approval of Clobivis

Eyewire News

03.24.2026

TP-03 Now Approved in China for the Treatment of Demodex Blepharitis

Eyewire News

03.20.2026

Artelo Biosciences Enters Clinical Study Agreement to Evaluate Novel Cannabinoid Therapy for Glaucoma

Eyewire News
FDA Issues Third Complete Response Letter to Aldeyra Therapeutics for Dry Eye Drug Reproxalap image

03.17.2026

FDA Issues Third CRL to Aldeyra Therapeutics for Dry Eye Drug Reproxalap

Eyewire News

02.23.2026

Lupin Secures European Commission Approval for Biosimilar Ranibizumab Ranluspec

Eyewire News

02.20.2026

FDA Officially Shifts to One-Trial Standard for New Drug Approvals

Eyewire News
Eye PCR Receives CE Mark for fixOflex Endocapsular Device, Plans European Launch image

02.13.2026

Eye PCR Receives CE Mark for fixOflex Endocapsular Device, Plans European Launch

Eyewire News

02.11.2026

Eco-Friendly, Sustainable Cataract Surgery

Ahmet Akman, MD, FACS, and Sirel Gür Güngör, MD

Cataract and Refractive Surgery Today link out
BVI Announces First US Implantations of FDA-Approved Finevision HP Trifocal IOL image

02.10.2026

BVI Announces First US Implantations of FDA-Approved Finevision HP Trifocal IOL

Eyewire News

01.21.2026

The Economics of Innovation in Rare Eye Disease: Lessons from Epithelium-On Corneal Cross-Linking

Richard Lindstrom, Kendall Donaldson, and Rajesh Rajpal

Cataract and Refractive Surgery Today link out
SpyGlass Pharma Randomizes First Patients in Phase 3 Trials of BIM-IOL System for Glaucoma image

01.21.2026

SpyGlass Pharma Randomizes First Patients in Phase 3 Trials of BIM-IOL System for Glaucoma

Eyewire News
BVI Announces Leadership Transition image

01.19.2026

BVI Announces Leadership Transition

Eyewire News
FDA Issues Another CRL to Outlook Therapeutics for Wet AMD Drug Candidate Lytenava image

12.31.2025

FDA Issues Another CRL to Outlook Therapeutics for Wet AMD Drug Candidate Lytenava

Eyewire News

View More